Hi Goldust, i do not think that there are too many shares freely available, which will work well if we have good news and as you say the reverse if we have bad news, I think that someone had been selling for the past few months and this brought the price down. I feel that the price should be a bit higher yet and I am hoping that we get news of improved trading due to revenue from the trials announced lasy year building. I was expecting a trading statement this week as it was announced on 19th Oct last year but may have been delayed as Dereck Hill is addressing the conference in Washington and he would probably prefer to be here.
I like it Dereck Hill is presenting at The Coalition Against Major Diseases in Washington, he commented. Biosensor technologies are set to revolutionise drug development and patient care when used in the appropriate clinical context and regulatory framework. Ixico is delighted to share our cutting-edge work with regulators and experts in the pharmaceutical industry.
Another nice contract announced today. There was a trading statement on 19th Oct last year so lets hope for more news next week. Prior to this they had nine early stage contracts so revenue should be building.
I cleared out my holding here just because of another opportunity (luckily before the drop). I would have thought it should be red hot for a takeover by the likes of IBM for its medical imaging analytics etc. very surprised at the SP. will be back in
Someone selling, it does not take many to push the price down, also it does not take many to push the price up. Should be a trading statement in about a month, early stage of nine trials with revenue building and a great announcement today, liked the last bit on RNS, prior to production rollout. Working with Biogen a $66 billion market cap company
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.